398 related articles for article (PubMed ID: 7520631)
21. Immunosuppressive effects of defibrotide.
Ferraresso M; Rigotti P; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1993 Oct; 56(4):928-33. PubMed ID: 8212219
[TBL] [Abstract][Full Text] [Related]
22. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection.
Fukuzawa M; Okada A
Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483
[No Abstract] [Full Text] [Related]
23. Effect of FK 506 and lipo prostaglandin E1 on heart allograft survival in rats.
Uchino T; Belboul A; Olausson M; Mjörnstedt L; Roberts D; Berglin E
Scand Cardiovasc J; 1999; 33(6):362-5. PubMed ID: 10622549
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive mechanisms of deoxymethylspergualin and FK 506 on in vitro cytotoxic T lymphocytes.
Nakata S; Shirakura R; Ito T; Fukuzawa M; Miyagawa S; Yamamoto S; Nozaki T; Matsumiya G; Izutani H; Matsuda H
Transplant Proc; 1994 Aug; 26(4):1930-2. PubMed ID: 7520613
[No Abstract] [Full Text] [Related]
25. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
[No Abstract] [Full Text] [Related]
26. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
27. Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation.
Kato H; Inamoto T; Kanaya S; Uyama S; Uemoto S; Tanaka K; Yamaoka Y
Transplant Proc; 1994 Apr; 26(2):893-5. PubMed ID: 7513481
[No Abstract] [Full Text] [Related]
28. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
[No Abstract] [Full Text] [Related]
29. Cellular mechanisms: induction of heart allograft survival in rats by 15-deoxyspergualin.
Jiang H; Takahara S; Kyo M; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transpl Int; 1992; 5 Suppl 1():S497-500. PubMed ID: 14621858
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiles of rat heart allografts with immunosuppression.
Erickson LM; Yang XF; Pan F; Kobayashi M; Jiang H
Transplant Proc; 2001; 33(1-2):562-6. PubMed ID: 11266960
[No Abstract] [Full Text] [Related]
31. Effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
Ueda H; Itoh S; Azuma H; Isurugi K; Yutani C
Eur Surg Res; 1994; 26(6):380-7. PubMed ID: 7851464
[TBL] [Abstract][Full Text] [Related]
32. Combined use of deoxyspergualin and FK 506 for temporary circulatory assist.
Hachida M; Maeda T; Bonkohara Y; Nonoyama M; Niinami H; Koyanagi H
Transplant Proc; 1999 Aug; 31(5):2049-55. PubMed ID: 10455968
[No Abstract] [Full Text] [Related]
33. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
[No Abstract] [Full Text] [Related]
34. Effects of interferon alpha/beta on cardiac allografts.
Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
[No Abstract] [Full Text] [Related]
35. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
[No Abstract] [Full Text] [Related]
36. Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin.
Muramatsu K; Doi K; Kawai S
J Hand Surg Am; 1999 May; 24(3):586-93. PubMed ID: 10357540
[TBL] [Abstract][Full Text] [Related]
37. AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report.
Fang YH; Joo DJ; Lim BJ; Kim JY; Kim MS; Jeong HJ; Kim YS
Transplant Proc; 2010 Apr; 42(3):976-9. PubMed ID: 20430219
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411
[No Abstract] [Full Text] [Related]
39. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
[TBL] [Abstract][Full Text] [Related]
40. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival.
Kuroki H; Bean MA; Ikuta Y; Akiyama M; Burgess EM
Transplant Proc; 1993 Feb; 25(1 Pt 1):658-61. PubMed ID: 7679833
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
